GA-binding protein α/β is a critical regulator of the BRCA1 promoter

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

  2007cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.

  1999cited by this paper
• Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

  1999cited by this paper
• Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

  1999cited by this paper
• Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta.

  1999cited by this paper
• Identification of a GABPα/β Binding Site Involved in the Induction of Oxytocin Receptor Gene Expression in Human Breast Cells. Potentiation by c-Fos/c-Jun.

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999cited by this paper
• Positive Regulation of the BRCA1 Promoter*

  1999influential reference
• Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers

  1998cited by this paper
• Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region

  1998cited by this paper
• Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta.

  1998cited by this paper
• CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site

  1998cited by this paper
• Regulation of the rat thyrotropin receptor gene by the methylation-sensitive transcription factor GA-binding protein.

  1998cited by this paper
• The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.

  1998cited by this paper
• Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells

  1998cited by this paper
• Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype.

  1998cited by this paper
• Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells

  1997cited by this paper
• BRCA1 expression is not directly responsive to estrogen

  1997cited by this paper
• Casein Kinase II-mediated Phosphorylation of the C Terminus of Sp1 Decreases Its DNA Binding Activity*

  1997cited by this paper
• The BRCA1 and BRCA2 breast cancer genes.

  1997cited by this paper
• Complex Regulation of the BRCA1 Gene*

  1997influential reference
• GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.

  1997cited by this paper
• Mutation analysis in the BRCA2 gene in primary breast cancers

  1996cited by this paper
• BRCA2 mutations in primary breast and ovarian cancers

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Low incidence of BRCA2 mutations in breast carcinoma and other cancers

  1996cited by this paper
• Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation

  1996cited by this paper
• Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

  1996cited by this paper
• Functional domains of transcription factor hGABP beta1/E4TF1-53 required for nuclear localization and transcription activation.

  1996cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Distinct transcription start sites generate two forms of BRCA1 mRNA.

  1995cited by this paper
• Somatic mutations in the BRCA1 gene in sporadic ovarian tumours

  1995cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Molecular and genetic characterization of GABP beta.

  1994cited by this paper
• THE PREVIOUS INCARNATION OF THE OLD NOVA GK-PERSEI

  1994cited by this paper
• Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promoters.

  1993cited by this paper

• GABPB1 plays a cancer-promoting role in non-small cell lung cancer

  2024cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications

  2020cites this paper
• lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter

  2020cites this paper
• Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer

  2020cites this paper
• SNPs in lncRNA Regions and Breast Cancer Risk

  2020cites this paper
• Leveraging genomic and molecular variations to understand the regulatory landscape in human cancers and differentiating stem cells

  2019cites this paper
• BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

  2018cites this paper
• Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition

  2018cites this paper
• The ETS family of oncogenic transcription factors in solid tumours

  2017cites this paper
• The Microenvironment of Lung Cancer and Therapeutic Implications.

  2016cites this paper
• Folic acid supplementation in vitro induces cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA methylation of their promoters or DNA repair.

  2015cites this paper
• THE NRF-1/GABP/BRCA1 Transcriptional Network in Mammary Epithelial Differentiation

  2012cites this paper
• c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells

  2011cites this paper
• Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex

  2011cites this paper
• Abnormal expression of NRF-2α in hepatocellular carcinoma identified with a newly prepared monoclonal antibody against human NRF-2α protein

  2011cites this paper
• A critical re-appraisal of BRCA1 methylation studies in ovarian cancer.

  2010cites this paper
• Identification and Characterization of Novel Kinases that Regulate BRCA1 Expression and Function

  2010cites this paper
• MOLECULAR STRESS SIGNALING IN BREAST EPITHELIAL CELLS Characterization of the Regulation of the Breast Cancer Susceptibility Gene 1 (BRCA1) by Stress Signaling and Design of an Epidemiological Study Examining the Effect of Glucocorticoid Receptor Genetic Variants on Breast Cancer Risk

  2007cites this paper
• Characterisation of BRCA1 genomic rearrangements in South African breast and/or ovarian cancer families

  2007cites this paper
• Characterization of a negative transcriptional element in the BRCA1 promoter

  2007cites this paper
• A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells

  2006cites this paper
• Microcompetition and the origin of cancer.

  2005cites this paper
• DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter

  2004cites this paper
• GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.

  2004cites this paper
• BRCA1 in hormone-responsive cancers.

  2003cites this paper
• Transcriptional regulation of the murine brca2 gene by CREB/ATF transcription factors.

  2003cites this paper
• Ets-2 and Components of Mammalian SWI/SNF Form a Repressor Complex That Negatively Regulates the BRCA1Promoter*

  2003cites this paper
• The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer

  2003cites this paper
• Identification of genes induced by BRCA1 in breast cancer cells.

  2002cites this paper
• Cell-cycle-dependent Regulation of Human aurora A Transcription Is Mediated by Periodic Repression of E4TF1*

  2002cites this paper
• Regulation of BRCA1 expression and its relationship to sporadic breast cancer

  2002cites this paper
• Functional analysis of CpG methylation in the BRCA1 promoter region

  2001cites this paper
• Expression profiles and intergenic structure of head-to-head oriented Brca1 and Nbr1 genes.

  2001cites this paper
• Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.

  2001cites this paper
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001cites this paper
• A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element

  2001cites this paper